Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UniFluVec Phase I in Healthy Volunteers
NCT04650971Phase 1Completed
- Sponsor
- Pharmenterprises
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of UniFluVec in Influenza A (IAV) (3 arms), sponsored by Pharmenterprises. Primary endpoint: Number of Adverse events. Started Aug 2019; status: completed.
02
Drugs
UniFluVec
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT04650971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04650971.